Maxigen Biotech Inc. announced the appointment of Lin Yung-Hsiang, Liao Sung-Yuan, Li Shi Ming, Zeng Zhong Ming and Chen Ching-Ting to the newly formed risk management committee effective as on May 3, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
41.95 TWD | -0.94% | -3.78% | -13.33% |
May. 06 | Maxigen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 21 | Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-13.33% | 117M | |
-0.29% | 260B | |
+19.91% | 20.41B | |
0.00% | 19.12B | |
+16.86% | 12.78B | |
-15.06% | 9.11B | |
+25.38% | 8.31B | |
+12.97% | 5.91B | |
-9.35% | 4.15B | |
-17.45% | 3.81B |
- Stock Market
- Equities
- 1783 Stock
- News Maxigen Biotech Inc.
- Maxigen Biotech Inc. Appoints Members of the Company's Risk Management Committee